Human gene therapy trials for AIDS begin

Reuters reports:

“California biotechnology company Sangamo BioSciences Inc. said on Monday it will start human testing of a new approach to treating the AIDS virus that involves deliberately damaging the patient’s DNA. The approach is based on research that has long shown that people with a certain mutation in a gene called CCR5 resist infection with the fatal and incurable virus.”

Here is a link to the company’s press release.